Dr Kai Lindevall has been re-appointed chief executive of contract research organisation (CRO) Encorium, having held the post in 2008 …
Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Dr Lloyd Payne as its new research director. He joins Aquapharm from …
Mark Cater has been appointed managing director of Chamberlain Healthcare PR’s London office. Prior to joining Chamberlain, Cater was regional …
The University of Cambridge is to join Eli Lilly’s ‘Open Innovation Drug Discovery’ project. Lilly first launched its online portal …

Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …
Our round-up of developments in the world of outsourced R&D includes job losses at Charles River, India’s SIRO Clinpharma buying …
The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …
AstraZeneca and cancer diagnostics specialist Dako Denmark are to develop companion diagnostics for a number of the pharma company’s oncology …
A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …
Patients with advanced soft tissue sarcoma could now benefit from PharmaMar’s new drug trabectedin, after the NICE granted its approval. …
US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …

The Medical Research Council’s chief executive Sir Leszek Borysiewicz is stepping down later this year to become vice chancellor of …

Amsterdam-based technology company Avantium has appointed Gunnar Staaf as chief executive of its pharma business in preparation for spinning it …

A number of pharmaceutical companies have sprung into action to help the relief effort in Haiti. The island has been …
The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …
NICE is moving to update its clinical guidance on the management of chronic heart failure in adults. Draft recommendations are …

Irish contract research organisation ICON has appointed Bruce Given chairman.He succeeds out-going chairman John Climax who co-founded the company in 1990 …

Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …
The head of Monitor, the body charged with regulating the leading ‘foundation trust’ hospitals, has aired his views on the …

Cephalon’s executive vice president of worldwide pharmaceutical operations Robert Roche is leaving the company at the beginning of February to …